GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut. Show more

North Tower, Stamford, CT, 06902, United States

Diagnostics & Research
Healthcare
Start AI Chat

Market Cap

2.517B

52 Wk Range

$55.17 - $170.87

Previous Close

$87.08

Open

$84.02

Volume

1,141,442

Day Range

$80.15 - $85.34

Enterprise Value

3.351B

Cash

155.1M

Avg Qtr Burn

N/A

Insider Ownership

13.38%

Institutional Own.

-

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date